NEWARK, NEWCASTLE, USA, April 23, 2023 (GLOBE NEWSWIRE) — According to a recent Growth Plus Reports study, Automated immunoassay device market presumed to hit US$2.23 billion by 2031profitable CAGR 5.80%The study examines key strategies, drivers and prospects, competitive landscape, changing market dynamics, market size, data and forecasts, and key investment regions.
Important points:
- Rising need to diagnose microbial-based diseases will drive market revenue growth.
- Rising Need for Prevention and Control of Serious Disease Drives Demand for Automated Immunoassay Analyzers
- North America dominates the global automated immunoassay analyzer market.
Get a sample copy of the research report. https://www.growthplusreports.com/inquiry/request-sample/automated-immunoassay-analyzers-market/8551
Market scope of automated immunoanalyzers
| report attribute | detail |
| Market size value in 2022 | US$1.34 billion |
| Revenue forecast for 2031 | US$2.23 billion |
| growth rate | 5.8% CAGR from 2023 to 2031 |
| Estimation base year | 2022 |
| Forecast period | 2023-2031 |
| history year | 2021 |
| Target segment | Products, Applications, End Users, and Regions. |
| Area range | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
market driver
Growing need to diagnose and identify microbial-based diseases drives revenue growth of the automated immunoassay analyzer market. In addition, increasing severe disease requirements for prevention and control, and increasing chronic disease conditions, including cancer and autoimmune diseases, are expected to boost the market revenue growth rate. Apart from this, aging population, rapid lifestyle changes, and increasing smoking and drinking habits are expected to support the revenue growth of the market.
market segmentation
Growth Plus Reports has analyzed the global automated immunoassay analyzer market from four perspectives: product, application, end user, and region.
Product segmentation: Based on product, the global automated immunoassay analyzer market is segmented into immunofluorescence, chemiluminescence, enzyme-linked fluorescence systems, and radioimmunoassay. The chemiluminescence segment, as a result of huge R&D expenditures aimed at providing new solutions and correcting problems in the current product portfolio, is growing due to the increased popularity of lab automation and products, as well as broad clinical applications. , dominates the market with the largest revenue share.
Application segmentation: Based on application, the global automated immunoassay analyzer market is segmented into infectious diseases, endocrinology, drug monitoring, chronic diseases, and allergy testing. The infectious diseases segment dominates the market due to the rising prevalence of infectious diseases in developing countries.
End User Segmentation: Based on end user, the global automated immunoassay analyzer market is segmented into academic research institutions, biotechnology and pharmaceutical companies, hospitals, and diagnostic laboratories. The hospital sector dominates the market due to the increasing need in the hospital sector for immunoassay products for chronic diseases and infectious diseases.
Regional growth dynamics
Based on region, the global automated immunoassay analyzer market is segmented into North America, Europe, Asia-Pacific, and the rest of the world.
North America dominates the global automated immunoassay analyzer market, accounting for the largest revenue share of the market. Rising prevalence of chronic diseases, increased use of technology, rising health care costs, strong need for greater health at lower prices, availability of well-developed infrastructure, significant corporate presence is the main factor. It is responsible for North America’s significant revenue share in the global market.
Customization Request – https://www.growthplusreports.com/inquiry/customization/automated-immunoassay-analyzers-market/8551
competitive environment
The major players in the global automated immunoassay analyzer market are:
- Bio-Rad Laboratories
- siemens healthcare
- Carolina Liquid Chemistry Corporation
- Roche Diagnostics
- Orthoclinical diagnosis
- Luminex Co., Ltd.
- Merrill Life Science
- Abbott Laboratories
- Landox Institute
- Becton Dickinson and Company
- aesque diagnosis
- BioMérieux
- Arlington Scientific
The market for automated immunoassay analyzers is somewhat competitive with several multinational companies. Major competitors engage in technological advancements, research and development, mergers and acquisitions to strengthen their market positions.
Recent developments:
- VIDAS KUBE is the next generation automated immunoassay system in the renowned VIDAS series, CE marked in December 2022 by bioMérieux, the world leader in in vitro diagnostics. Help treat patients and protect consumers.
table of contents
- prologue
- market ecosystem
- timeline under consideration
- Historic year – 2021
- Base Year – 2022
- Forecast Year – 2023 to 2031
- Currency used in reports
- research method
- research approach
- Data collection method
- data source
- secondary source
- primary source
- Market estimation approach
- bottom up
- top down
- Market forecast model
- Limitations and Assumptions
- Premium Insight
- Current Market Trends (COVID-19 Perspective)
- Key Players and Competitive Positioning (2022)
- Regulatory status
- market dynamics
- driver
- restraint/challenge
- chance
- Global Automated Immunoassay Analyzer Market – Analysis and Forecast by Product
- immunofluorescence
- chemiluminescence
- Enzyme-linked fluorescence system
- radioimmunoassay
- Global Automated Immunoassay Analyzer Market Analysis and Forecast by Application
- Infection
- endocrinology
- drug monitoring
- chronic disease
- allergy test
- Global Automated Immunoassay Analyzer Market – Analysis and Forecast by End-Users
- Academic research institute
- biotech and pharmaceutical companies
- hospital
- diagnostic laboratory
Automated Immunoassay Analyzer Market TOC
Purchase this premium research report: https://www.growthplusreports.com/checkout-8551
Value proposition related to the report:
- Featuring free analyst time and expert interviews for each report
- Comprehensive quantitative and qualitative insights at segment and subsegment level
- Covid 19 impact trends and outlook
- Detailed insights at global/regional/country level
- Deep insight into market dynamics (drivers, constraints, opportunities) and business environment
- Comprehensive coverage of the competitive environment
- victory conditions
- Exhaustive coverage on “strategic developments” registered by key players in the market
Customization options:
- Distributor Landscape Assessment
- price intelligence
- Customer base evaluation
- Analysis of investments and initiatives
- “Business Profiles” of Key Players
Schedule a call with an analyst. https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/Introduction
– Visit our report store. https://www.growthplusreports.com/report-store
Browse our latest healthcare reports:
speculum market By Type (Reusable, Disposable), Material Type (Stainless Steel, Plastic), End User (Hospitals, Specialty Clinics) – Global Outlook and Forecasts 2023-2031
Arthroscopic shaver market By Type (Plastic, Polycarbonate, Stainless Steel), Application (Hip Arthroscopy, Spine Arthroscopy), End User (Hospitals, Ambulatory Surgery Centers) – Global Outlook and Forecast 2023-2031
Klinefelter Syndrome Hormone Therapy Market Drug Delivery (Oral, Topical) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy) – Global Outlook and Forecast 2023-2031
HIV/HBV/HCV test kit market By Type (Rapid Test Kits and Assay-Based Test Kits), Samples (Blood, Saliva), End Users (Hospitals, Diagnostic Laboratories) – Global Outlook and Forecasts 2023-2031
Blood cancer diagnostic market By Type (Products, Services), Test Type (Blood Test, Bone Marrow Biopsy, Imaging), Cancer Type (Leukemia, Multiple Myeloma), End User (Hospitals, Academic Research Institutions) – 2023 to 2031 World Outlook and Forecasts to 2020
about us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge services company. We are proud to be members of the EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus’ portfolio of services leverages core capabilities such as secondary and primary research, market modeling and forecasting, benchmarking, analytics, and strategy development to create scalable, breakthrough solutions that prepare clients for future growth and success. We will help you to do so.
We have been honored as “Most Innovative Healthcare Market Research Firm in 2020” by the prestigious CEO Magazine.
